Results 231 to 240 of about 573,740 (334)

Assessing Effects of Riboflavin/UV‐A Cross‐Linking on Aqueous Outflow Facility, Corneal Biomechanics and Their Association With Intraocular Pressure

open access: yesJournal of Biophotonics, Volume 19, Issue 2, February 2026.
Our study demonstrates that UV cross‐linking (CXL) reduces outflow facility while increasing corneal elasticity across IOP levels of 20–40 mmHg, measured using direct manometry and non‐contact optical coherence elastography. These results highlight both parameters as potential indicators for evaluating CXL effectiveness and monitoring keratoconus ...
Yilong Zhang   +6 more
wiley   +1 more source

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT There are a number of guidelines on how to manage obesity, but inconsistencies in healthcare access, varying infrastructure, resource constraints and diverse local practices restrict their global applicability. This underscores the need for universal recommendations that address the unique challenges faced by patients and healthcare providers ...
Stefan D. Anker   +60 more
wiley   +1 more source

Traditional Chinese Medicine Modernization in Diagnosis and Treatment: Utilizing Artificial Intelligence and Nanotechnology

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Traditional Chinese medicine (TCM) faces great challenges during the development of modern medicine. Utilizing novel technologies such as artificial intelligence (AI) and nanotechnology facilitates TCM with great potential in precision diagnosis and improved treatments efficacy.
Wenqi Yu   +7 more
wiley   +1 more source

Comparing the Molecular Pharmacological Properties of Existing β‐Blockers to Determine the Theoretically Most “Ideal” Anti‐Cancer β‐Blocker

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT There is increasing evidence, from cellular, animal and human epidemiological studies, linking β‐blockers with reductions in cancer growth and metastasis. Propranolol is the most investigated β‐blocker for cancer; although as many different off‐patent β‐blockers exist, there is little commercial incentive to drive comparative clinical trials ...
Jillian G. Baker
wiley   +1 more source

Nanobiotechnology‐Based Approaches for Uveal Melanoma Treatment

open access: yesSmartMat, Volume 7, Issue 1, February 2026.
Emerging platforms for uveal melanoma combine precision drug delivery, ROS‐amplifying modalities, and nucleic acid transport to overcome ocular barriers and immunosuppressive niches. Targeted nanoparticles, virus‐like constructs, and injectable depots enable localized activation, controlled release, and gene‐level reprogramming.
Nadezhda A. Pechnikova   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy